Global Human Cytomegalovirus Envelope Glycoprotein B Market Insights and Forecast to 2026

Global Human Cytomegalovirus Envelope Glycoprotein B Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Human Cytomegalovirus Envelope Glycoprotein B Product Introduction
1.2 Market Segments
1.3 Key Human Cytomegalovirus Envelope Glycoprotein B Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate by Type
1.4.2 CSJ-148
1.4.3 CyMVectin
1.4.4 TRL-345
1.4.5 PPCM
1.4.6 Cytomegalovirus Vaccine
1.4.7 Others
1.5 Market by Application
1.5.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate by Application
1.5.2 Infectious Disease
1.5.3 Oncology
1.5.4 Women's Health
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size, Estimates and Forecasts
2.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue 2015-2026
2.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales 2015-2026
2.2 Global Human Cytomegalovirus Envelope Glycoprotein B, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Human Cytomegalovirus Envelope Glycoprotein B Competitor Landscape by Players
3.1 Human Cytomegalovirus Envelope Glycoprotein B Sales by Manufacturers
3.1.1 Human Cytomegalovirus Envelope Glycoprotein B Sales by Manufacturers (2015-2020)
3.1.2 Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Manufacturers (2015-2020)
3.2 Human Cytomegalovirus Envelope Glycoprotein B Revenue by Manufacturers
3.2.1 Human Cytomegalovirus Envelope Glycoprotein B Revenue by Manufacturers (2015-2020)
3.2.2 Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Human Cytomegalovirus Envelope Glycoprotein B Revenue in 2019
3.2.5 Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Human Cytomegalovirus Envelope Glycoprotein B Price by Manufacturers
3.4 Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base Distribution, Product Types
3.4.1 Human Cytomegalovirus Envelope Glycoprotein B Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Product Type
3.4.3 Date of International Manufacturers Enter into Human Cytomegalovirus Envelope Glycoprotein B Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Type (2015-2020)
4.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2015-2020)
4.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2015-2020)
4.1.3 Human Cytomegalovirus Envelope Glycoprotein B Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Type (2021-2026)
4.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Type (2021-2026)
4.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Type (2021-2026)
4.2.3 Human Cytomegalovirus Envelope Glycoprotein B Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Application (2015-2020)
5.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2015-2020)
5.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2015-2020)
5.1.3 Human Cytomegalovirus Envelope Glycoprotein B Price by Application (2015-2020)
5.2 Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Application (2021-2026)
5.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Application (2021-2026)
5.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Price Forecast by Application (2021-2026)
6 North America
6.1 North America Human Cytomegalovirus Envelope Glycoprotein B by Country
6.1.1 North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country
6.1.2 North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Type
6.3 North America Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Application
7 Europe
7.1 Europe Human Cytomegalovirus Envelope Glycoprotein B by Country
7.1.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country
7.1.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Type
7.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B by Region
8.1.1 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Region
8.1.2 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Type
8.3 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Application
9 Latin America
9.1 Latin America Human Cytomegalovirus Envelope Glycoprotein B by Country
9.1.1 Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country
9.1.2 Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Type
9.3 Central & South America Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B by Country
10.1.1 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country
10.1.2 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Type
10.3 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Application
11 Company Profiles
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Corporation Information
11.1.2 Astellas Pharma Inc. Description and Business Overview
11.1.3 Astellas Pharma Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Products Offered
11.1.5 Astellas Pharma Inc. Related Developments
11.2 Trellis Bioscience, Inc.
11.2.1 Trellis Bioscience, Inc. Corporation Information
11.2.2 Trellis Bioscience, Inc. Description and Business Overview
11.2.3 Trellis Bioscience, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Products Offered
11.2.5 Trellis Bioscience, Inc. Related Developments
11.3 Vakzine Projekt Management GmbH
11.3.1 Vakzine Projekt Management GmbH Corporation Information
11.3.2 Vakzine Projekt Management GmbH Description and Business Overview
11.3.3 Vakzine Projekt Management GmbH Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Products Offered
11.3.5 Vakzine Projekt Management GmbH Related Developments
11.4 VBI Vaccine Inc
11.4.1 VBI Vaccine Inc Corporation Information
11.4.2 VBI Vaccine Inc Description and Business Overview
11.4.3 VBI Vaccine Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Products Offered
11.4.5 VBI Vaccine Inc Related Developments
11.5 Vical Incorporated
11.5.1 Vical Incorporated Corporation Information
11.5.2 Vical Incorporated Description and Business Overview
11.5.3 Vical Incorporated Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Products Offered
11.5.5 Vical Incorporated Related Developments
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Corporation Information
11.1.2 Astellas Pharma Inc. Description and Business Overview
11.1.3 Astellas Pharma Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Products Offered
11.1.5 Astellas Pharma Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Human Cytomegalovirus Envelope Glycoprotein B Market Estimates and Projections by Region
12.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Regions 2021-2026
12.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Regions 2021-2026
12.2 North America Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast (2021-2026)
12.2.1 North America: Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast (2021-2026)
12.2.2 North America: Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast (2021-2026)
12.2.3 North America: Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country (2021-2026)
12.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast (2021-2026)
12.3.1 Europe: Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast (2021-2026)
12.3.2 Europe: Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast (2021-2026)
12.3.3 Europe: Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Region (2021-2026)
12.5 Latin America Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast (2021-2026)
12.5.1 Latin America: Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast (2021-2026)
12.5.2 Latin America: Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast (2021-2026)
12.5.3 Latin America: Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Human Cytomegalovirus Envelope Glycoprotein B Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Cytomegalovirus Envelope Glycoprotein B Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Human Cytomegalovirus Envelope Glycoprotein B Market Segments
Table 2. Ranking of Global Top Human Cytomegalovirus Envelope Glycoprotein B Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of CSJ-148
Table 5. Major Manufacturers of CyMVectin
Table 6. Major Manufacturers of TRL-345
Table 7. Major Manufacturers of PPCM
Table 8. Major Manufacturers of Cytomegalovirus Vaccine
Table 9. Major Manufacturers of Others
Table 10. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Regions (2015-2020)
Table 14. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Manufacturers (2015-2020)
Table 17. Global Human Cytomegalovirus Envelope Glycoprotein B Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Human Cytomegalovirus Envelope Glycoprotein B by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Cytomegalovirus Envelope Glycoprotein B as of 2019)
Table 19. Human Cytomegalovirus Envelope Glycoprotein B Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Price (2015-2020) (USD/Pcs)
Table 22. Human Cytomegalovirus Envelope Glycoprotein B Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Product Type
Table 24. Date of International Manufacturers Enter into Human Cytomegalovirus Envelope Glycoprotein B Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2015-2020) (K Pcs)
Table 27. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Type (2015-2020)
Table 28. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Type (2015-2020)
Table 30. Human Cytomegalovirus Envelope Glycoprotein B Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2015-2020) (K Pcs)
Table 32. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Application (2015-2020)
Table 33. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2015-2020) (K Pcs)
Table 34. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2015-2020)
Table 35. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2015-2020)
Table 37. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2015-2020) (K Pcs)
Table 38. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2015-2020)
Table 39. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2015-2020) (K Pcs)
Table 40. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2015-2020)
Table 41. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2015-2020)
Table 43. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2015-2020)
Table 45. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2015-2020)
Table 47. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2015-2020)
Table 57. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2015-2020)
Table 61. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2015-2020)
Table 63. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2015-2020)
Table 73. Astellas Pharma Inc. Corporation Information
Table 74. Astellas Pharma Inc. Description and Major Businesses
Table 75. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Astellas Pharma Inc. Product
Table 77. Astellas Pharma Inc. Recent Development
Table 78. Trellis Bioscience, Inc. Corporation Information
Table 79. Trellis Bioscience, Inc. Description and Major Businesses
Table 80. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Trellis Bioscience, Inc. Product
Table 82. Trellis Bioscience, Inc. Recent Development
Table 83. Vakzine Projekt Management GmbH Corporation Information
Table 84. Vakzine Projekt Management GmbH Description and Major Businesses
Table 85. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Vakzine Projekt Management GmbH Product
Table 87. Vakzine Projekt Management GmbH Recent Development
Table 88. VBI Vaccine Inc Corporation Information
Table 89. VBI Vaccine Inc Description and Major Businesses
Table 90. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. VBI Vaccine Inc Product
Table 92. VBI Vaccine Inc Recent Development
Table 93. Vical Incorporated Corporation Information
Table 94. Vical Incorporated Description and Major Businesses
Table 95. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Vical Incorporated Product
Table 97. Vical Incorporated Recent Development
Table 98. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Regions (2021-2026) (K Pcs)
Table 99. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Forecast by Regions (2021-2026)
Table 100. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 101. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share Forecast by Regions (2021-2026)
Table 102. North America: Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2021-2026) (K Pcs)
Table 103. North America: Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Europe: Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2021-2026) (K Pcs)
Table 105. Europe: Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Asia Pacific: Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Region (2021-2026) (K Pcs)
Table 107. Asia Pacific: Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Region (2021-2026) (US$ Million)
Table 108. Latin America: Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2021-2026) (K Pcs)
Table 109. Latin America: Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Middle East and Africa: Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2021-2026) (K Pcs)
Table 111. Middle East and Africa: Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 113. Key Challenges
Table 114. Market Risks
Table 115. Main Points Interviewed from Key Human Cytomegalovirus Envelope Glycoprotein B Players
Table 116. Human Cytomegalovirus Envelope Glycoprotein B Customers List
Table 117. Human Cytomegalovirus Envelope Glycoprotein B Distributors List
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Cytomegalovirus Envelope Glycoprotein B Product Picture
Figure 2. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type in 2020 & 2026
Figure 3. CSJ-148 Product Picture
Figure 4. CyMVectin Product Picture
Figure 5. TRL-345 Product Picture
Figure 6. PPCM Product Picture
Figure 7. Cytomegalovirus Vaccine Product Picture
Figure 8. Others Product Picture
Figure 9. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application in 2020 & 2026
Figure 10. Infectious Disease
Figure 11. Oncology
Figure 12. Women's Health
Figure 13. Others
Figure 14. Human Cytomegalovirus Envelope Glycoprotein B Report Years Considered
Figure 15. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size 2015-2026 (US$ Million)
Figure 16. Global Human Cytomegalovirus Envelope Glycoprotein B Sales 2015-2026 (K Pcs)
Figure 17. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2015-2020)
Figure 19. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region in 2019
Figure 20. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2015-2020)
Figure 21. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region in 2019
Figure 22. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Human Cytomegalovirus Envelope Glycoprotein B Revenue in 2019
Figure 24. Human Cytomegalovirus Envelope Glycoprotein B Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2015-2020)
Figure 26. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type in 2019
Figure 27. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2015-2020)
Figure 28. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type in 2019
Figure 29. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Price Range (2015-2020)
Figure 30. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2015-2020)
Figure 31. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application in 2019
Figure 32. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2015-2020)
Figure 33. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application in 2019
Figure 34. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country in 2019
Figure 37. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country in 2019
Figure 38. U.S. Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Human Cytomegalovirus Envelope Glycoprotein B Market Share by Type in 2019
Figure 43. North America Human Cytomegalovirus Envelope Glycoprotein B Market Share by Application in 2019
Figure 44. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country in 2019
Figure 47. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country in 2019
Figure 48. Germany Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Human Cytomegalovirus Envelope Glycoprotein B Market Share by Type in 2019
Figure 59. Europe Human Cytomegalovirus Envelope Glycoprotein B Market Share by Application in 2019
Figure 60. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region in 2019
Figure 63. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region in 2019
Figure 64. China Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Share by Type in 2019
Figure 87. Asia Pacifi

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs